About
1.35USD+0.04 +3.05%
Closed • Updated at 19:09 GMT+00:00Market Cap$50.82M
Volume180.7K
Beta1.69
RSI47.45
Gross Margin76.56%
Metagenomi Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 11 2026
Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results
Apr 16 2026
Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency
Mar 5 2026
Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results
Feb 23 2026
Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference
Jan 12 2026
Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook
Community Chat
Ask AI
Try asking
Translate